In this Fox News featured interview, Dotmatics VP of Science, Alister Campbell, discusses how AI and digital transformation are accelerating drug discovery and reshaping the future of scientific research. Reflecting on the five-year anniversary of COVID-19’s pandemic declaration, Alister explores how AI-driven insights, collaboration, and automation have helped streamline research and improve patient outcomes.
Key topics include:
How AI is reducing drug development timelines from a decade to just a few years
The role of AI in precision medicine and clinical trial optimization
Why human expertise remains critical in AI-driven research
Learn More About Dotmatics
Schedule a meeting with our product experts today for a personalized demo of Luma's AI capabilities.